Bristol-Myers Squibb Company Common Stock (BMY): Debt Offering News

BMY – Files mixed securities shelf offering.


Key Facts Surrounding This News Item


  • BMY had a POWR Rating of B (Buy) coming into today.
  • BMY was -0.48% below its 10-Day Moving Average coming into today.
  • BMY was -0.10% below its 20-Day Moving Average coming into today.
  • BMY was 2.89% above its 50-Day Moving Average coming into today.
  • BMY was 8.87% above its 100-Day Moving Average coming into today.
  • BMY was 2.86% above its 200-Day Moving Average coming into today.
  • BMY had returned +0.72% year-to-date leading up to today’s news, versus a +9.24% return from the benchmark S&P 500 during the same period.

More Info About Bristol-Myers Squibb Company Common Stock (BMY)


Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York. View our full BMY ticker page with ratings, news, and more.

BMY at a Glance

BMY Current POWR Rating™
Overall POWR Rating™
BMY Current Price $53.27 1.29%
More BMY Ratings, Data, and News

BMY Price Reaction

The day of this event (Sep. 12, 2018)
BMY Closing Price$59.94 0.26%
BMY Volume7,070,643
0.64% from avg
Leading up to this event
BMY 1-mo returnN/A%
After this event
BMY 1-day return0.49%
BMY 3-day return1.32%
BMY 5-day return0.51%

BMY Price Chart



More Bristol-Myers Squibb Company Common Stock (BMY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BMY News
Page generated in 0.649 seconds.